Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,262.65
+3,063.31
(+6.49%)
MONEY
Best savings accounts that offer above inflation rates
Where to find a top-rated deal that works for you
NeuBase Therapeutics, Inc. (NBSE)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4050
-0.0061
(-1.48%)
At close: 04:00PM EDT
0.3782
-0.03
(-6.62%)
After hours:
07:42PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
Operating expenses
Research development
18,431
21,449
14,363
6,946
Selling general and administrative
11,530
11,870
12,202
10,123
Total operating expenses
29,961
33,318
26,565
17,069
Operating income or loss
-29,961
-33,318
-26,565
-17,069
Interest expense
10.696
24.047
32.33
7.686
Total other income/expenses net
-739.692
-582.62
1,176
-307.528
Income before tax
-30,417
-33,776
-25,409
-17,385
Income from continuing operations
-30,417
-33,776
-25,409
-17,385
Net income
-30,417
-33,776
-25,409
-17,385
Net income available to common shareholders
-30,417
-33,776
-25,409
-17,385
Basic EPS
-18.60
-20.80
-18.60
-17.80
Diluted EPS
-18.60
-20.80
-18.60
-17.80
Basic average shares
1,628
1,624
1,365
981.014
Diluted average shares
1,628
1,624
1,365
981.014
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.